The past, present and future of renin-angiotensin aldosterone system inhibition

被引：92

作者：

Mentz, Robert J. ^{[1
]}

Bakris, George L. ^{[2
]}

Waeber, Bernard ^{[3
,4
]}

McMurray, John J. V. ^{[5
]}

Gheorghiade, Mihai ^{[6
]}

Ruilope, Luis M. ^{[7
]}

Maggioni, Aldo P. ^{[8
]}

Swedberg, Karl ^{[9
]}

Pina, Ileana L. ^{[10
]}

Fiuzat, Mona ^{[1
]}

O'Connor, Christopher M. ^{[1
]}

Zannad, Faiez ^{[11
]}

Pitt, Bertram ^{[12
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27710 USA

[2] Univ Chicago Med, Chicago, IL USA

[3] CHU Vaudois, Lausanne, Switzerland

[4] Univ Lausanne, Lausanne, Switzerland

[5] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[6] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA

[7] Hosp 12 Octubre, E-28041 Madrid, Spain

[8] Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy

[9] Univ Gothenburg, Gothenburg, Sweden

[10] Montefiore Einstein Med Ctr, New York, NY USA

[11] Ctr Invest Clin, Nancy, France

[12] Univ Michigan, Sch Med, Univ Hosp, Ann Arbor, MI USA

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 05期

关键词：

Renin-angiotensin aldosterone system; Hypertension; Heart failure; Myocardial infarction; Clinical trials; CONVERTING-ENZYME-INHIBITORS; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; MINERALOCORTICOID RECEPTOR ACTIVATION; HIGH-RISK PATIENTS; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RANDOMIZED-TRIAL; II-RECEPTOR;

D O I：

10.1016/j.ijcard.2012.10.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The renin-angiotensin aldosterone system (RAAS) is central to the pathogenesis of cardiovascular disease. RAAS inhibition can reduce blood pressure, prevent target organ damage in hypertension and diabetes, and improve outcomes in patients with heart failure and/or myocardial infarction. This review presents the history of RAAS inhibition including a summary of key heart failure, myocardial infarction, hypertension and atrial fibrillation trials. Recent developments in RAAS inhibition are discussed including implementation and optimization of current drug therapies. Finally, ongoing clinical trials, opportunities for future trials and issues related to the barriers and approvability of novel RAAS inhibitors are highlighted. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：1677 / 1687

页数：11

共 50 条

[21] TO THE ORIGINS OF RENOPROTECTIVE IN CHRONIC KIDNEY DISEASE: PAST AND PRESENT OF THE RENIN-ANGIOTENSIN SYSTEM
Ivanova, Mariya
Vetchinnikova, Olga
Zulkarnaev, Aleksei
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 38 - 38
[22] The effect of direct renin inhibition alone or in combination with angiotensin II receptor blockade on markers of the renin-angiotensin aldosterone system
Frandsen, E.
Persson, R.
Boomsma, F.
Prescott, M.
Dole, N. P.
Rossing, P.
Parving, H. -H.
DIABETOLOGIA, 2008, 51 : S491 - S492
[23] PROSTACYCLIN STIMULATES THE RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM IN MAN
MIYAMORI, I
FITZGERALD, GA
BROWN, MJ
LEWIS, PJ
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (06): : 943 - 944
[24] ROLE OF RENIN-ANGIOTENSIN SYSTEM IN CONTROL OF ALDOSTERONE SECRETION
SLATER, JDH
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (12): : 1251 - &
[25] ROLE OF RENIN-ANGIOTENSIN SYSTEM IN CONTROL OF ALDOSTERONE IN MAN
BOYD, GW
ADAMSON, AR
JAMES, VHT
PEART, WS
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (12): : 1253 - &
[26] RENIN-ANGIOTENSIN SYSTEM IN CONTROL OF ALDOSTERONE SECRETION IN RAT
DAVIS, JO
SPIELMAN, WS
ACTA PHYSIOLOGICA LATINOAMERICANA, 1974, 24 (05) : 399 - 404
[27] Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
Stiefel, P.
Vallejo-Vaz, A. J.
Morillo, S. Garcia
Villar, J.
INTERNATIONAL JOURNAL OF HYPERTENSION, 2011, 2011
[28] THE RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM IN HUMAN HEPATIC CIRRHOSIS
BERNARDI, M
GASBARRINI, G
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1986, 22 (02): : 70 - 77
[29] ROLE OF RENIN-ANGIOTENSIN SYSTEM IN CONTROL OF ALDOSTERONE SECRETION
DAVIS, JO
TITUS, EO
SPIEGEL, HE
CARPENTER, CCJ
AYERS, CR
HARTROFT, PM
JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (02): : 378 - &
[30] MODULATION OF ALDOSTERONE PRODUCTION BY THE ADRENAL RENIN-ANGIOTENSIN SYSTEM
KUSANO, E
STONER, G
FRANCOSAENZ, R
MULROW, PJ
CLINICAL RESEARCH, 1987, 35 (06): : A885 - A885

← 1 2 3 4 5 →